Live Status Check

NCT06815471 Recruiting Status

Real-time enrollment status for this worsening heart failure clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: November 17, 2026 at 7:48 AM UTC

NCT06815471 Status Summary

NCT NumberNCT06815471
Recruiting StatusRecruiting
ConditionWorsening Heart Failure
PhasePHASE2
Target Enrollment210 participants
Active Locations7 sites in the US
SponsorCorteria Pharmaceuticals
Last Updated on CT.govNovember 16, 2026 (Yesterday)

About NCT06815471 Enrollment Status

As of November 17, 2026: Clinical trial NCT06815471 is currently recruiting participants. This phase2 study for worsening heart failure is actively seeking new participants at 7 locations across the United States. The study is sponsored by Corteria Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06815471

Is NCT06815471 still recruiting?

Yes, NCT06815471 is actively recruiting participants as of November 17, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06815471 recruiting?

This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06815471?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06815471 status last updated?

The official ClinicalTrials.gov record for NCT06815471 was last updated Yesterday (November 16, 2026). HelloStudys verifies this status automatically.

Browse More Worsening Heart Failure Trials

Ready to Apply?

Check your eligibility for this clinical trial